Search Within

Michael David Offin

  1. "Darragh Halpenny"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  3. Department of Medicine (7)
  4. GSK Faculty (7)
  5. Solid Tumor Oncology Division (7)
  6. Thoracic Oncology (7)

More Groups

People
  1. Alexander Drilon (7)
  2. Charles Rudin (7)
  3. Darragh Halpenny (7)
  4. Mark Kris (7)
  5. Bob Li (6)
  6. Gregory Riely (5)

More People

Years
  1. 2022 (1)
  2. 2019 (4)
  3. 2018 (2)
Publications
  1. Journal of Clinical Oncology (2)
  2. Annals of Oncology (1)
  3. British Journal of Cancer (1)
  4. Clinical Cancer Research (1)
  5. JCO Precision Oncology (1)
  6. Journal of Thoracic Oncology (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers
    Meeting Abstract

    Offin, M.; Xu, C.; Jain, H.; Makhnin, A.; Hayes, S. A.; Plodkowski, A. J.; Halpenny, D.; Rudin, C. M.; Kris, M. G.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden
    Journal Article

    Benayed, R.; Offin, M.; Mullaney, K.; Sukhadia, P.; Rios, K.; Desmeules, P.; Ptashkin, R.; Won, H.; Chang, J.; Halpenny, D.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Immunophenotype and response to immunotherapy of RET-rearranged lung cancers
    Journal Article

    Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
    Journal Article

    Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save